Based on the provided data and context, I'll analyze whether HPQ is overvalued through multiple valuation metrics and recent performance.
Valuation Analysis
HPQ currently trades at a P/E ratio of 12.66x, which is relatively low compared to its historical range and the technology sector average. The EV/EBITDA ratio of 8.08x also suggests reasonable valuation from an enterprise value perspective.
Financial Performance
Revenue has shown minimal growth, with Q4 2024 revenue at $14.05 billion representing only a modest increase from previous quarters. Net income improved to $906 million in Q4 2024, showing better profitability despite challenging market conditions.
Analyst Sentiment
Recent analyst actions indicate mixed views, with Bernstein raising their price target to $34 while maintaining a Hold rating. HSBC downgraded HPQ to Hold from Buy with a $38 target, citing cost pressures expected to continue in early 2025.
Based on these factors, HPQ is not overvalued at current levels, supported by reasonable valuation multiples, improving profitability, and analyst price targets indicating potential upside.